Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of high-dose escitalopram (up to 50 mg) for major depressive disorder
2008-003359-58Phase 4Completed
- Sponsor
- CPS Research
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of escitalopram in major depressive disorder (MDD), sponsored by CPS Research. Primary endpoint: Safety and tolerability of escitalopram up to 50 mg. Started Jun 2008; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-003359-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003359-58.